Cell Therapy

News

Bayer backs cell therapy ambition with $250m US facility

Bayer is backing up its move into the cell therapy category led by subsidiary BlueRock Therapeutics with a $250 million investment in a new manufacturing facility in Berke

News

FDA advisors unconvinced by BrainStorm’s ALS cell therapy

An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to su

Oncology

CAR-TCR 2023 – Jason Noon

If we learned anything at CAR-TCR it’s that CAR-T therapies are still a relatively new treatment modality and innovation is happening along many different axes.

News

Novo Nordisk Foundation pledges €127m for cell therapy plant

The Novo Nordisk Foundation is funding the creation of a cell therapy development and manufacturing facility in Denmark with one of the largest investments in the sector i

News

Changes ring at Oxford Bio as ABL takeover talks progress

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europ

News

FDA capacity forces delay to Iovance's cell therapy

Iovance Biotherapeutics is facing a three-month delay in the review of its lifileucel cell therapy for melanoma in the US, held up by "insufficient resources" at the FDA.

Bayer backs cell therapy ambition with $250m US facility

FDA advisors unconvinced by BrainStorm’s ALS cell therapy

CAR-TCR 2023 – Jason Noon

Novo Nordisk Foundation pledges €127m for cell therapy plant

Changes ring at Oxford Bio as ABL takeover talks progress

FDA capacity forces delay to Iovance's cell therapy

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Cell Therapy

Editor's Picks